The development and initial validation of IgG4-related disease damage index: a consensus report from Chinese IgG4-RD Consortium

Linyi Peng,Jingna Li,Jiaxin Zhou,Yunyun Fei,lingli Dong,Yan-Ying Liu,Dingding Zhang,Yanhong Wang,Shuhong Chi,Fang Wang,Yunxia Hou,Xiaoping Hong,Hongsheng Sun,Yujin Ye,Nan Che,Rong Zhang,Changyan Liu,Zongfei Ji,Wenjia Sun,Cheng Zhao,Ning Ma,Yamin Lai,Mengtao Li,Yan Zhao,Xiaofeng Zeng,Liwei Lu,Wen Zhang
DOI: https://doi.org/10.1136/rmdopen-2023-003938
2024-03-09
RMD Open
Abstract:Objective To develop and conduct an initial validation of the Damage Index for IgG4-related disease (IgG4-RD DI). Methods A draft of index items for assessing organ damages in patients with IgG4-RD was generated by experts from the Chinese IgG4-RD Consortium (CIC). The preliminary DI was refined using the Delphi method, and a final version was generated by consensus. 40 IgG4-RD cases representing four types of clinical scenarios were then selected, each with two time points of assessment for at least 3 years of follow-up. 48 rheumatologists from 35 hospitals nationwide were invited to evaluate organ damage using the CIC IgG4-RD DI. The intraclass correlation coefficient (ICC) and the Kendall-W coefficient of concordance (KW) were used to assess the inter-rater reliability. The criterion validity of IgG4-RD DI was tested by calculating the sensitivity and specificity of raters. Results IgG4-RD DI is a cumulative index consisting of 14 domains of organ systems, including a total of 39 items. The IgG4-RD DI was capable of distinguishing stable and increased damage across the active disease subgroup and stable disease subgroup. In terms of scores at baseline and later observations by all raters, overall consistency in scores at baseline and later observations by all raters was satisfactory. ICC at the two time points was 0.69 and 0.70, and the KW was 0.74 and 0.73, respectively. In subgroup analysis, ICC and KW in all subgroups were over 0.55 and 0.61, respectively. The analysis of criterion validity showed a good performance with a sensitivity of 0.86 (95% CI 0.82 to 0.88), a specificity of 0.79 (95% CI 0.76 to 0.82) and an area under the curve of 0.88 (95% CI 0.85 to 0.91). Conclusion The IgG4-RD DI is a useful approach to analyse disease outcomes, and it has good operability and credibility. It is anticipated that the DI will become a useful tool for therapeutic trials and studies of prognosis in patients with IgG4-RD.
rheumatology
What problem does this paper attempt to address?
The problem this paper attempts to address is the development and preliminary validation of an index for assessing organ damage in patients with IgG4-related disease (IgG4-RD), namely the IgG4-RD Damage Index (IgG4-RD DI). Specifically, the study aims to design a scoring system capable of evaluating irreversible organ damage and dysfunction associated with IgG4-RD, including damage caused by the disease itself and damage induced by treatment. Additionally, the study aims to test the criterion validity and inter-rater reliability of this damage index. IgG4-RD is a recently recognized chronic systemic fibro-inflammatory disease that can affect multiple organs and may lead to irreversible organ damage, dysfunction, and even death. Despite significant progress in understanding the pathogenesis, clinical features, diagnosis, and treatment of IgG4-RD, many unmet needs remain, particularly in assessing disease activity and treatment efficacy. The existing IgG4-RD Response Index (RI) can evaluate disease activity and treatment efficacy but has limitations in assessing the severity of organ damage and does not include damage caused by medications or other treatments. Therefore, developing a new damage index is of great importance for assessing patient prognosis and long-term disease burden.